Marginum develops fluorescence-based tissue detection systems to improve surgical performance and cost-effectiveness.
Marginum has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in August 2025.
Marginum's investors include Redstone.VC, Business Finland, Almaral, Nostetta Ventures, Restone Capital.
Marginum is headquartered in Kuopio, Finland.
Marginum develops fluorescence-based tissue detection systems to improve surgical performance and cost-effectiveness.
Marginum is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Marginum — Funding & Investors." VCBacked, August 22, 2025, https://www.vcbacked.co/company/marginum. Accessed July 26, 2026.
VCBacked. (2025). Marginum — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/marginum
{{cite web |title=Marginum — Funding & Investors |url=https://www.vcbacked.co/company/marginum |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated